Related Experiment Video
Updated: May 24, 2026
10:44
A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function
Published on: June 2, 2019
CD19+CD5+ cells as indicators of preeclampsia
Federico Jensen1, Gerd Wallukat, Florian Herse
1Experimental Obstetrics and Gynecology, Medical Faculty, Otto-von-Guericke University, Gerhart-Hauptmann-Str 35, 39108 Magdeburg, Germany. federico.jensen@med.ovgu.de
Hypertension (Dallas, Tex. : 1979)
|February 23, 2012
Summary
Preeclampsia involves autoantibodies. Researchers identified CD19(+)CD5(+) B-1a B cells as the source of these autoantibodies, which target the angiotensin type 1 receptor II, offering potential diagnostic markers for preeclampsia.
Area of Science:
- Immunology
- Obstetrics
- Reproductive Medicine
Background:
- Preeclampsia is a pregnancy disorder linked to autoimmune responses.
- Autoantibodies against the angiotensin type 1 receptor II are implicated in preeclampsia symptoms.
- The specific B cell population responsible for these autoantibodies remains unidentified.
Purpose of the Study:
- To identify the B cell subpopulation producing autoantibodies in preeclampsia.
- To investigate the regulation of these B cells.
- To assess their potential as disease markers.
Main Methods:
- Flow cytometry to analyze peripheral blood B cell populations.
- In vitro lymphocyte culture with human chorionic gonadotropin stimulation.
- Detection of B cells in placental tissue.
Main Results:
- A significant increase in CD19(+)CD5(+) B-1a cells in preeclamptic patients' blood.
- CD19(+)CD5(+) cells express human chorionic gonadotropin receptors and expand upon stimulation.
- These cells produce autoantibodies against angiotensin type 1 receptor II and are found in preeclamptic placentas.
Conclusions:
- CD19(+)CD5(+) B-1a cells are identified as the source of pathogenic autoantibodies in preeclampsia.
- Human chorionic gonadotropin influences the expansion of these cells.
- These B cells represent potential diagnostic and therapeutic targets for preeclampsia.
